Discussion: Transvenous phrenic nerve stimulation for central sleep apnea.

22 May 2016 (08:47 - 08:50)

Organised by:

Video

Sign in for access options

11 More presentations in this session

Presentation thumbnail

Cardiovascular improvements with minute ventilation-targeted adaptive servo-ventilation (MV-ASV) therapy in heart failure.

Doctor C. O'Connor (Washington, DC, US)

Presentation thumbnail

Discussion: minute ventilation-targeted adaptive servo-ventilation.

Presentation thumbnail

Transvenous phrenic nerve stimulation for central sleep apnea.

Doctor M. Costanzo (Naperville, US)

Presentation thumbnail

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in chronic heart failure patients with and without diabetes.

Doctor A. Jorsal (Aarhus, DK)

Presentation thumbnail

Discussion: Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in chronic heart failure patients with and without diabetes.

Access the full session

Session thumbnail

Late Breaking Trials II: Focus on chronic heart failure

The Event

HEART FAILURE 2016

22 May 2016 08:47 CET

You may be interested in

Congress Presentation

Discussant review - remede System Pivotal Trial Heart Failure Win Ratio Analysis

12 May 2024

Congress Session

Cardioneuroablation

31 March 2025

Congress Presentation

Catheter-based cardiopulmonary nerve stimulation impacts left ventricular contractility and relaxation: first in human experience

1 July 2021

Congress Presentation

Vagus nerve stimulation for chronic heart failure: differences in therapy delivery and clinical efficacy in ANTHEM-HF, INOVATE-HF, and NECTAR-HF

2 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources